Yibin Zheng

USPTO Granted Patents = 38 (Patent Applications = 77)

CIPO Patents = 1 (Patent Applications = 13)

EPO Patents = 4 (Patent Applications = 46)

Average Co-Inventor Count = 3.5

ph-index = 6

Forward Citations = 230(Granted Patents)

Location History:

Schenectady, NY (US) (2001)
Rexford, NY (US) (2002)
Charlottesville, VA (US) (2004 - 2005)
Hartland, WI (US) (2011 - 2024)

Company Filing History:

General Electric Company

patents

2 out of 5,259

Lockheed Martin Corporation

patents

Years Active: 2001-2025

Loading Chart...

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12433998 - Activity mode for artificial pancreas system (2025-10-07),

2. 12431229 - Medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions (2025-09-30),

3. 12427251 - User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system (2025-09-30),

4. 12409270 - Optimizing embedded formulations for drug delivery (2025-09-09),

5. 12406760 - Exercise safety prediction based on physiological conditions (2025-09-02),

6. 12370309 - Adaptive update of automatic insulin delivery (AID) control parameters (2025-07-29),

7. 12370307 - Use of fuzzy logic in predicting user behavior affecting blood glucose concentration in a closed loop control system of an automated insulin delivery device (2025-07-29),

8. 12343501 - Techniques to reduce risk of occlusions in drug delivery systems (2025-07-01),

9. 12257420 - Initial total daily insulin setting for user onboarding (2025-03-25),

10. 12226612 - Compensation for missing readings from a glucose monitor in an automated insulin delivery system (2025-02-18),

11. 12121701 - Systems and methods for incorporating co-formulations of insulin in an automatic insulin delivery system (2024-10-22),

12. 12097355 - Automatically or manually initiated meal bolus delivery with subsequent automatic safety constraint relaxation (2024-09-24),

13. 12090301 - Safety constraints for a control algorithm based drug delivery system (2024-09-17),

14. 12036389 - Prediction of meal and/or exercise events based on persistent residuals (2024-07-16),

15. 11986630 - Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk (2024-05-21),

Title: Yibin Zheng: Innovator in Automated Insulin Delivery Systems

Introduction: Yibin Zheng, a prominent inventor based in Hartland, Wisconsin, holds an impressive portfolio of 29 patents. His work primarily revolves around innovations in automated insulin delivery systems, aiming to improve the management of diabetes through cutting-edge technology.

Latest Patents: Among his latest contributions, Zheng has developed several significant patents. One noteworthy invention addresses the issue of missing readings from glucose monitors in automated insulin delivery systems. This innovative solution utilizes estimates in place of absent blood glucose concentration readings, ensuring that insulin delivery is not interrupted due to connectivity issues. This allows the automated insulin delivery device to continue functioning effectively, maintaining the user's diabetes management.

Another of Zheng's recent patents involves the integration of co-formulations of insulin with additional drugs, like GLP-1, in automated delivery systems. This system calculates the appropriate dose of insulin while considering the effects of the second drug on the user's overall insulin requirements, thus enhancing the efficiency of diabetes treatment.

Career Highlights: Yibin Zheng has previously worked with major companies like Insulet Corporation and General Electric Company. His innovative work has significantly impacted the field of automated diabetes management, showcasing his dedication to enhancing patient care through technological advancements.

Collaborations: Throughout his career, Zheng has collaborated with notable professionals in the field, including Joon Bok Lee and Jason B. O'Connor. These partnerships have fueled the innovative spirit behind his inventions and contributed to the successful development of new medical technologies.

Conclusion: Yibin Zheng's contributions to the field of automated insulin delivery systems highlight his role as a leading inventor in diabetes management technology. With 29 patents to his name, his ongoing innovations continue to pave the way for improved health outcomes for individuals managing diabetes, establishing him as a key figure in this vital area of medical research and development.

This text is generated by artificial intelligence and may not be accurate.